Journal
ONCOLOGIST
Volume 16, Issue 1, Pages 87-96Publisher
ALPHAMED PRESS
DOI: 10.1634/theoncologist.2010-0213
Keywords
EBV; Epstein-Barr virus; Diffuse large B-cell lymphoma; DLBCL; Elderly; Review
Categories
Ask authors/readers for more resources
Epstein-Barr virus-positive (EBV-positive) diffuse large B-cell lymphoma (DLBCL) of the elderly is a newly described lymphoproliferative disorder recently included as a provisional entity in the most current WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. The objective of this review is to provide a thorough and current summary of the existing knowledge of this subtype of DLBCL. We will review and discuss the incidence of EBV expression in DLBCL, the pathogenesis behind EBV-driven malignant transformation of B cells, the different EBV latency patterns associated with DLBCL, the distinct pathologic characteristics of EBV-positive DLBCL, the potential predictive and prognostic value of EBV tumoral status in patients with DLBCL, and potential strategies for the treatment of this rare entity, which is characterized by a suboptimal response to therapy and poor survival rate. The Oncologist 2011; 16: 87-96
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available